According to prior studies, the activation of NF-κB contributes to chemotherapy resistance [11, 12], and the inhibition of NF-κB could enhance cytotoxic effects of chemotherapeutic drugs in cervical cancer [43]. The gene discussed is NFKB1; the disease is cervical cancer.